May 26 is the last chance for the lowest Epic Pass price of the year Epic Pass unlocks access to world-class mountain resorts year-round; Scenic gondola rides and exclusive savings on lodging, dining, bike rentals and golf among the many summer benefits for Pass Holders  BROOMFIELD, Colo., May 6, 2025 /PRNewswire/ -- Your Epic Pass is not just for winter experiences. As snow covered slopes at your favorite mountain resorts transform into stunning hiking and biking trails, 2025/26 Epic Pass Holders will get ...

Financial Data and Key Metrics Changes - The company reported adjusted earnings per share of $0.70 and total segment operating profit of $747 million for the quarter [5] - Trailing fourth quarter adjusted return on invested capital (ROIC) was 7% and cash flow from operations before working capital changes was $439 million [5][24] - Overall cash flow from operations decreased compared to the prior quarter due to lower total segment operating profit [24] Business Line Data and Key Metrics Changes - The Carbohydrate Solutions segment operating profit was $240 million, down 3% year-over-year [20] - The Nutrition segment revenues were $1.8 billion, down 1% year-over-year, while operating profit increased by 13% to $95 million [22][23] - The Ag Services and Oilseeds segment operating profit was $412 million, down 52% compared to the prior year quarter [16] Market Data and Key Metrics Changes - The Ag Services sub-segment operating profit was $159 million, down 31% due to lower North American origination export volumes [17] - Global trade results were lower compared to the same quarter last year, largely due to negative timing impacts [17] - Equity earnings from the company's investment in Wilmar were $72 million, down 52% compared to the prior year quarter [20] Company Strategy and Development Direction - The company is focused on cost savings of $500 million to $750 million over the next three to five years, including workforce reductions and a review of third-party consulting spend [9] - Strategic decisions include the closure of the Cursea, South Carolina crush facility and the exit from domestic trading operations in China and Dubai [10] - The company is advancing automation and digitization across its global manufacturing network to improve reliability and efficiency [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the team's ability to navigate an uncertain external landscape while focusing on execution and cost management [12][31] - The company remains cautious about the second half outlook for crush margin improvement due to current domestic crush replacement margins being below expectations [26] - Management highlighted the importance of clarity on Renewable Volume Obligations (RVOs) to support strong U.S. demand for crop-based vegetable oils [34] Other Important Information - The company returned $247 million to shareholders in the form of dividends during the quarter [25] - The Decatur East facility is expected to be fully operational by the end of the second quarter, with an anticipated impact of $25 million per quarter for Nutrition once fully operational [99] Q&A Session Summary Question: Expectations for RVO and its impact on 2025 outlook - Management indicated that strong RVOs are crucial for the biofuel outlook and expect margins to improve in the second half of the year [40][41] Question: Specific RVO numbers and positive outcomes for ADM - Management mentioned that the industry requires approximately €25 billion in biomass-based biodiesel and conventional biodiesel to support internal consumption and export markets [51][52] Question: Strength in RPO despite a weak environment - Management acknowledged that while RPO was better in the short run, overall expectations remain lower due to biodiesel margin pressures and increased refining capacity [58][59] Question: Trade flow shifts and impact of tariffs - Management noted that the impact of tariffs has not been significant in Q1, with most products exempt from export tariffs to Mexico and Canada [64][66] Question: Signs of rationalization in the soy crush industry - Management speculated that the industry may see plant shutdowns when demand is low, but emphasized the importance of clarity on RPO mandates for future capacity [73][74] Question: Commercialization of Argentine crops - Management expects Argentine farmers to become more regular in commercializing crops as they take advantage of government tax benefits before they expire [79] Question: Volume growth expectations for Starches and Sweeteners - Management reiterated guidance for slightly lower volumes than last year, with some weakness noted in specific markets [82][84] Question: Ethanol margins and performance - Management highlighted good risk management in ethanol operations, with expectations for margins to improve over the year [90] Question: Contribution from Decatur once fully operational - Management confirmed that the Decatur plant's impact will be felt in the second half of the year, with an expected contribution of $25 million per quarter [99]

TreeHouse Foods (THS) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Company Participants Matt Siler - Vice President of Investor RelationsSteven Oakland - President, CEO & ChairmanPatrick O'Donnell - Executive Vice President and CFO Conference Call Participants Jon Andersen - Equity Research Analyst - ConsumerJim Salera - Research AnalystScott Marks - Equity Research AnalystWilliam Reuter - Analyst Operator Welcome to the TreeHouse Foods First Quarter twenty twenty five Conference Call. All participants ar ...

Cabot (CBT) Q2 2025 Earnings Call May 06, 2025 08:00 AM ET Company Participants Steven Delahunt - VP of Investor Relations & TreasurerSean Keohane - Director, President & CEOErica McLaughlin - EVP, CFO and Head of Corporate StrategyJohn Roberts - Managing DirectorJosh Spector - Executive DirectorDan Rizzo - Senior Vice President Conference Call Participants Jeffrey Zekauskas - Analyst Operator Good day and thank you for standing by. Welcome to the Cabot Second Quarter twenty twenty five Earnings Conference ...

TreeHouse Foods (THS) Q1 2025 Earnings Call May 06, 2025 08:30 AM ET Speaker0 Welcome to the TreeHouse Foods First Quarter twenty twenty five Conference Call. All participants are in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this call is being recorded. At this time, I would like to turn the call over to TreeHouse Foods for the reading of the Safe Harbor statement. Speaker1 Good morning and thank you for joining us today. Earlier this morning, ...

Cabot (CBT) Q2 2025 Earnings Call May 06, 2025 08:00 AM ET Speaker0 Good day and thank you for standing by. Welcome to the Cabot Second Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Steve Della Hunt, Vice President, Treasurer and Investor ...

Exxon Mobil (XOM) Q1 2025 Earnings Call May 02, 2025 09:30 AM ET Company Participants Jim Chapman - VP - Treasurer and Investor RelationsDarren Woods - Chairman and CEOBetty Jiang - Managing DirectorDevin Mcdermott - Executive DirectorKathryn Mikells - EVP & CFONeil Mehta - Head of Americas Natural Resources Equity ResearchJohn Royall - Executive DirectorBiraj Borkhataria - Global Head, Energy Transition ResearchJean Ann Salisbury - Managing DirectorBob Brackett - Head - Research DivisionJosh Silverstein - ...

Earnings Presentation 1Q 2025 1 First Quarter 2025 Highlights Operational Milestones $2.5 billion cash position provides significant optionality 1Q 2025 Financial Results $2.8B Net Sales $288M EBITDA(1) $2.5B Cash, Equivalents and Investments(2) (1) Reconciliation of EBITDA to Net Income (Loss), Income from Operations and Net Cash Provided by Operating Activities can be found on page 11 (2) Includes investments in available-for-sale securities 2 • 1Q'25 PEM EBITDA impacted by $100 million of YoY higher feed ...

Financial Data and Key Metrics Changes - Q2 sales were $479 million, a 17% year-on-year decrease, including a $67 million impact from portfolio optimization, resulting in a 5% revenue decline excluding this impact [8][12] - Adjusted EBITDA was $108 million, down 14% year-over-year, with an organic decline of 4% [8][12] - Adjusted EPS, excluding acquisition amortization, was $0.99 per share, down 22% from the prior year [13] Business Line Data and Key Metrics Changes - Life Sciences sales declined 23% year-over-year to $172 million, primarily due to portfolio optimization initiatives [16] - Personal Care sales decreased by 14% year-over-year to $146 million, largely due to divestitures and low-margin product exits [21] - Specialty Additives sales fell by 15% to $134 million, with organic sales down 9% [26] Market Data and Key Metrics Changes - The demand environment was mixed, with slower trends than expected, particularly in Europe and the U.S. [7][43] - Intermediates generated $2 million in adjusted EBITDA, representing a 5.4% adjusted EBITDA margin, down from $12 million in the prior year [20] Company Strategy and Development Direction - The company is focused on achieving a $90 million cost savings target and has completed its restructuring efforts ahead of schedule [28] - Strategic priorities include enhancing financial performance through controllable factors and navigating the evolving tariff landscape [28][35] - The company aims for $100 million in incremental revenue from its Globalize and Innovate initiatives by fiscal year 2027 [31] Management's Comments on Operating Environment and Future Outlook - Management noted increasing economic uncertainty and anticipated softer consumer demand, prompting an adjustment to the fiscal year 2025 outlook [10][49] - The company expects flattish organic sales volume growth for the full fiscal year, with a positive inflection anticipated in the second half [45] - Management emphasized the importance of adapting and executing with discipline to navigate near-term challenges [10][50] Other Important Information - The company has over $700 million in liquidity and a manageable net leverage of 2.8 times, positioning it well to navigate the current environment [15] - The completion of portfolio optimization is expected to enhance long-term profitability despite short-term impacts [10][50] Q&A Session Summary Question: Order volatility and customer expectations - Management observed reduced volatility in orders over the last two quarters, with volumes picking up and pricing aligning with guidance [54][55] Question: Mitigation of risks related to U.S. produced China sales - Management indicated that over half of the risks could be mitigated through customer partnerships and production shifts, although some challenges remain [58][60] Question: Impact of delayed reciprocal tariffs on other regions - Management noted limited impact from tariffs outside of China, with most raw materials sourced regionally [67][68] Question: Competitive pressures in Specialty Additives - Management reported stable conditions in China, with pricing pressures continuing but manageable [71][72] Question: Cash flow expectations for the year - Management expects free cash flow to be in the range of $150 million to $200 million, depending on inventory and FX developments [91]

Financial Data and Key Metrics Changes - Q2 sales were $479 million, a 17% year-on-year decrease, including a $67 million impact from portfolio optimization. Excluding this, the revenue decline was 5% mainly due to lower carryover volumes and pricing [7][12] - Adjusted EBITDA was $108 million, down 14% year-over-year or 4% organically, partially offset by cost savings initiatives [7][13] - Adjusted EPS, excluding acquisition amortization, was $0.99 per share, down 22% from the prior year [14] Business Line Data and Key Metrics Changes - Life Sciences sales declined 23% year-over-year to $172 million, primarily due to portfolio optimization initiatives [16] - Personal Care sales decreased by 14% year-over-year to $146 million, largely due to divestitures and low-margin product exits [22] - Specialty Additives sales fell by 15% to $134 million, with organic sales down 9% due to soft demand and competitive pressures [28] Market Data and Key Metrics Changes - The demand environment was mixed, trending slower than expected, particularly in Europe and the U.S. [6][46] - The intermediates market faced challenges with persistent supply-demand imbalances, impacting pricing and margins [47] Company Strategy and Development Direction - The company is focused on achieving a $90 million cost savings target and has made significant progress on restructuring and manufacturing optimization [30][34] - Strategic priorities include enhancing financial performance through controllable factors and maintaining a disciplined capital allocation strategy [55] Management's Comments on Operating Environment and Future Outlook - Management noted increasing economic uncertainty and anticipated softer consumer demand, prompting adjustments to the fiscal year '25 outlook [11][52] - The company expects flattish organic sales volume growth for the full fiscal year, with a positive inflection anticipated in the second half led by Life Sciences [48] Other Important Information - The company has a strong financial foundation with over $700 million in liquidity and a manageable net leverage of 2.8 times [15] - The completion of portfolio optimization is expected to enhance long-term profitability and focus [30] Q&A Session Summary Question: Order volatility and customer stability - Management noted reduced volatility in orders, with volumes picking up and pricing aligning with guidance, but sentiment in certain markets remains impacted [58][60] Question: Mitigation of U.S. produced China sales risk - Management indicated that over half of the risk could be mitigated through customer partnerships and production shifts, although some challenges remain [62][66] Question: Impact of reciprocal tariffs on supply chains - Management stated that outside of China, the impact of tariffs is minimal, with most raw materials sourced regionally [72][74] Question: Competitive pressures in Specialty Additives - Management observed stability in China, with no further declines in volumes or prices, while Europe remains flattish [78][80] Question: Cash flow expectations for the year - Management expects free cash flow to be in the range of $150 million to $200 million, depending on inventory and FX developments [94][96]